Levetiracetam is a drug within the pyrrolidine class that is used to treat various types of seizures stemming from epileptic disorders. It was first approved for use in the United States in 1999 and is structurally and mechanistically unrelated to other anti-epileptic drugs (AEDs).[L8606,L8600,L8615] Levetiracetam possesses a wide therapeutic index[L8615,A185918] and little-to-no potential to produce, or be subject to, pharmacokinetic interactions[L8606,L8600,L8615] - these characteristics make it a desirable choice over other AEDs, a class of drugs notorious for having generally narrow therapeutic indexes and a propensity for involvement in drug interactions.[A185927]
Synonyms
Levetiracetame
Levetiracetam
Lévétiracetam
Levetiracetamum
Brand Names
Elepsia XR 1000 mg
Levetiracetam Ratiopharm
Levetiractam
Levetiracetam Sun
Levetiracetam Levetiracetam
Nu-levetiracetam
Levetiracetam Extended Release
Levetiracetam Actavis
Keppra
Ach-levetiracetam
Levetiracetam Extended-Release
Novo-levetiracetam
Levetiracetam Teva
Van-levetiracetam
Keppra XR
Torrent-levetiracetam
Mint-levetiracetam Solution
Pharma-levetiracetam
Jamp-levetiracetam
Bio-levetiracetam
M-levetiracetam
Levetiracetam extended-release
Dom-levetiracetam
Elepsia XR
Teva-levetiracetam
Pro-levetiracetam - 750
Levetiracetam in Sodium Chloride
PHL-levetiracetam
Pro-levetiracetam - 250
Apo-levetiracetam
Levetiracetam Accord
Spritam
Roweepra
Matever
LEVETIRACETAM Extended-release
PMS-levetiracetam
Auro-levetiracetam
Mint-levetiracetam
Ag-levetiracetam
Pdp-levetiracetam
Levertiracetam
Tva-levetiracetam
Nra-levetiracetam
LEVETIRACETAM solution
Pro-levetiracetam - 500
Levetiracetam Actavis Group
Priva-levetiracetam
Roweepra XR
Ran-levetiracetam
Levetiracetam 1000 mg
Levetiracetam 250 mg
Levetiracetam
Ava-levetiracetam
Sandoz Levetiracetam
Elepsia XR 1500 mg
Levetiracetam ER
Abbott-levetiracetam
Levetiracetam Micro
Levetiracetam Extended-release
Levetiracetam 750 mg
Jamp Levetiracetam Tablets
Levetiracetam Injection USP
Riva-levetiracetam
Nat-levetiracetam
Levetiracetam Hospira
Indication
Levetiracetam is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older. Additionally, it is indicated as an adjunct in the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy who are 12 years of age and older, and in primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy who are 6 years of age and older.[L8606] Levetiracetam is also available as an orally dissolvable tablet that is indicated as an adjunct in the treatment of partial onset seizures in patients with epilepsy who are 4 years of age and older and weigh more than 20kg.[L8609]
Categories
Acetamides
Amides
Anticonvulsants
Central Nervous System Agents
Central Nervous System Depressants
Decreased Central Nervous System Disorganized Electrical Activity
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682